Oncternal Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
WILLS ROBERT JAMES director
 Common Stock 3,086 $8.96 $27,654
Purchase
WILLS ROBERT JAMES director
 Common Stock 6,914 $8.48 $58,603
Purchase
HALE DAVID F director
 Common Stock 266 $9.04 $2,405
Purchase
HALE DAVID F director
 Common Stock 714 $9.04 $6,455
Sale
WILLS ROBERT JAMES director
 Common Stock 980 $9.04 $8,859
Purchase
KAUFMANN GUNNAR F. officer: Chief Scientific Officer
 Common Stock 3,000 $0.36 $1,080
Purchase
KAUFMANN GUNNAR F. officer: Chief Scientific Officer
 Common Stock 25,000 $0.35 $8,750
Purchase
YAZJI SALIM officer: Chief Medical Officer
 Common Stock 5,000 $0.3 $1,500
Purchase
BREITMEYER JAMES B director, officer: Chief Execut..
 Common Stock 47,750 $0.3 $14,277
Purchase
BREITMEYER JAMES B director, officer: Chief Execut..
 Common Stock 2,250 $0.29 $653
Purchase
LEAVITT CHASE C. officer: General Counsel/Secret..
 Common Stock 10,000 $0.29 $2,900
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 30,000 $0.3 $8,970
Purchase
YAZJI SALIM officer: Chief Medical Officer
 Common Stock 10,000 $0.29 $2,850
Purchase
LEAVITT CHASE C. officer: General Counsel/Secret..
 Common Stock 15,000 $0.29 $4,350
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 2,500 $1.4 $3,500
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 2,136 $1.49 $3,183
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 5 $1.48 $7
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 356 $1.45 $516
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 3 $1.45 $4
Purchase
LEAVITT CHASE C. officer: General Counsel/Secret..
 Common Stock 5,000 $1.63 $8,150
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 2,500 $1.65 $4,125
Purchase
BREITMEYER JAMES B director, officer: Chief Execut..
 Common Stock 25,000 $1.68 $42,075
Purchase
YAZJI SALIM officer: Chief Medical Officer
 Common Stock 10,000 $1.69 $16,900
Purchase
LEAVITT CHASE C. officer: General Counsel/Secret..
 Common Stock 8,500 $1.78 $15,130
Purchase
VINCENT RICHARD G officer: Chief Financial Officer
 Common Stock 10,000 $1.75 $17,500
Sale
HALE DAVID F director
 Common Stock 3,669 $4.75 $17,428
Purchase
LEAVITT CHASE C.
Common Stock 1,500 $5.45 $8,175
Purchase
CARTER MICHAEL G director
 Common Stock 71,429 $2.1 $150,001
Purchase
SHANGHAI PHARMACEUTICAL (USA) INC. 10 percent owner
 Warrants 524,658 $2.32 $1,217,207
Purchase
AKER HAZEL M officer: Legal Counsel
 Common Stock 41,972 $2.38 $100,019
Purchase
KISNER DANIEL L director
 Common Stock 10,000 $2.38 $23,830
Purchase
SHANGHAI PHARMACEUTICAL (USA) INC. 10 percent owner
 Common Stock 1,049,317 $2.38 $2,500,522
Purchase
HALE DAVID F director
 Warrants 8,706 $2.51 $21,852
Purchase
HALE DAVID F director
 Common Stock 17,412 N/A N/A
Sale
YOUNG DIANE C. officer: VP, Chief Medical Offi..
 Common Stock 2,049 N/A N/A
Purchase
WILLS ROBERT JAMES director
 Common Stock 5,000 $16.75 $83,750
Sale
DOGGRELL HENRY PATTON officer: VP, Chief Legal Officer
 Common Stock 7,351 $19.01 $139,706
Sale
SHACKELFORD JASON T officer: Prin Fin. & Acct. Offi..
 Common Stock 9,279 N/A N/A
Sale
SHACKELFORD JASON T officer: Prin Fin. & Acct. Offi..
 Common Stock 3,090 $11.58 $35,767
Sale
DOGGRELL HENRY PATTON officer: VP, Chief Legal Officer
 Common Stock 4,965 $11.58 $57,470
Sale
HANOVER MARC STEVEN director, officer: Chief Execut..
 Common Stock 7,309 N/A N/A
Purchase
PYRAMID PEAK FOUNDATION 10 percent owner
 Common Stock Warrants (right to buy) 339,174 $9.02 $3,059,349
Purchase
PYRAMID PEAK FOUNDATION 10 percent owner
 Common Stock 565,291 N/A N/A
Sale
YOUNG DIANE C. officer: VP, Chief Medical Offi..
 Common Stock 500 $7.7 $3,850
Purchase
PYRAMID PEAK FOUNDATION 10 percent owner
 Common Stock 7,716,049 N/A N/A
Purchase
WILLS ROBERT JAMES director
 Common Stock 100,000 N/A N/A
Purchase
GLASS J KENNETH director
 Common Stock 44,000 N/A N/A
Purchase
HANOVER MARC STEVEN director, officer: Chief Execut..
 Common Stock 4,000 N/A N/A
Purchase
HANOVER MARC STEVEN director, officer: Chief Execut..
 Common Stock 12,813 N/A N/A
Purchase
HANOVER MARC STEVEN director, officer: Chief Execut..
 Common Stock 25,000 N/A N/A

Showing 1 to 50 of 318 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: